Cardiovascular Disease Network of Excellence
Working together to advance theory into practice, to improve outcomes for people with inherited & acquired cardiovascular disease.
What are we trying to do?
Improving outcomes through research into Brugada syndrome, AI-based Integrated Risk Scores and genetic diagnosis mainstreaming practices.
Why is this important?
Cardiovascular disease (CVD) is a leading cause of death worldwide, with 25% of all deaths registered in England and Wales being attributed to CVD. The NHS Long Term Plan has identified CVD as the main condition where lives can be saved.
This work will pilot approaches to improve the identification of individuals at risk of both inherited and acquired cardiovascular disease through using genomics to improve outcomes in a well-established and phenotyped cohort of patients.
Progress & next steps
We’re currently focusing on three areas which aim to improve outcomes for patients with cardiovascular disease. The three areas are:
- People with Brugada Syndrome
- Clinically validating a liquid biopsy test for Atherosclerotic Cardiovascular Disease
- Eliciting the role of nurses and allied health professionals in resolving the issues associated with diagnosing rare and inherited cardiac diseases
Who are we working with?
- St. George’s University Hospitals
- Barts NIHR
Article
Cardiovascular Network of Excellence
Watch a recording of our session with cardiac charities from across the country and learn more about cardio-genomics including our work in the Cardiovascular Network of Excellence.
